In recent weeks, a surprisingly contentious debate has been making headlines around the world: What role should artificial intelligence (AI) play in mathematics? The field, which has centuries-old methods of operating, sharing results, and acknowledging contributions, is grappling with how to…
CEO interview explores Ampligen’s potential to extend survival and improve quality of life as AIM advances toward pivotal development
KUALA LUMPUR: Anggota kumpulan Inteam, Muhammad Hazamin Harun menyifatkan luahan membabitkan seorang penyanyi nasyid yang mendakwa menerima layanan ‘double-standard’ oleh pihak media ketika Anugerah Industri Muzik (AIM) Ke-25 pada bulan lalu kerana salah faham yang berlaku atas faktor teknikal.…
OCALA, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent media coverage of the antiviral potential of Ampligen ® (rintatolimod), the Company’s investigational dsRNA and highly selective TLR3 agonist immunomodulator.
